Company / Current Liabilities
Kymera Therapeutics, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$83.2M
FY2025
5-year range
$67.8M / $92.5M
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
#112 of 213
Health Care
What the data says
At $83M, Kymera Therapeutics, Inc.'s current liabilities ranks #102 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 7 years, ranging from $35M in FY2019 to $111M in FY2020.
Based on SEC 10-K filings.
$83M in FY2025 with a 5-year CAGR of -5.5%.
Improved from $86M to $83M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
#102 of 213 in Health CareTop 47% of 213This company $83.2M Sector average $1.6B
▼
-94.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.5%, indicating a declining trend.
- In FY2025, current liabilities increased 22.8% year-over-year.
- Ranks #112 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.2M | +22.8% |
| FY2024 | $67.8M | -20.9% |
| FY2023 | $85.7M | +20.1% |
| FY2022 | $71.3M | -22.9% |
| FY2021 | $92.5M | -16.3% |
| FY2020 | $110.6M | +220.0% |
| FY2019 | $34.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026